William Dawson’s Post

View profile for William Dawson, graphic

International manufacturing and quality operations leader. Focused on sustainability and innovation. Inclusion and diversity sponsor

"Collaboration and joined up thinking is great, the need for joined up action is even more important." This quote has stayed with me since the recent The Association of the British Pharmaceutical Industry (ABPI) conference. I hosted a panel discussion there with experts from the industry and policymakers to discuss how the full potential of UK medicines manufacturing can be realised. I led the panel as the chair of the Medicines Manufacturing Industry Partnership, where we had excellent insights from the panelists. I also shared my own insights from my role as a manufacturing leader at GSK, where we have a significant footprint in the UK and across the world. I left the conference feeling confident and energised for many reasons - two stand out. First, the importance of government and industry partnership and the need for capital support, scale and longevity. Second, the focus on advanced and sustainable medicines manufacturing as a differentiator was clear. The innovation, research, regulatory processes and skills are all important focus areas. We now need to work together to continue to promote these areas, leverage these strengths and build on the progress being made. I want to say a big thank you to ABPI for creating a space to discuss this important topic. And thank you to the panelists @Roz Campion, John Arthur, Stella Peace and Stuart Carroll. I'm excited to see what can be achieved in the months and years ahead.  I commit to push for joined up action through the MMIP, as ultimately our efforts will result in more products for patients, and that's what matters most. #ABPIConf24

  • No alternative text description for this image
Chinmay Pande

Marketing Director at GSK

7mo

Hello William Dawson thanks for sharing … I believe this is the critical piece as the industry evolves … .. I have seen joined up thinking but speed in joined up execution is going to be key as things move forward …

Barry Heavey

Managing Director @ Accenture | Life Sciences Manufacturing & Quality, Clinical and Commercial Supply Chain

7mo

Some really exciting initiatives involving public-private partnerships in UK supporting innovation in manufacturing, especially for novel modalities like oligonucleotides. Props to organisations like CPI Medicines manufacturing centre

See more comments

To view or add a comment, sign in

Explore topics